The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 27, 2021
Filed:
Sep. 08, 2017
Applicant:
Beijing Hanmi Pharm. Co., Ltd., Beijing, CN;
Inventors:
Nanmeng Song, Beijing, CN;
Jiawang Liu, Beijing, CN;
Yaping Yang, Beijing, CN;
Yang Yang, Beijing, CN;
Dongge Yang, Beijing, CN;
Hongjuan Zhang, Beijing, CN;
Mengxie Jin, Beijing, CN;
Assignee:
BEIJING HANMI PHARM. CO., LTD., Beijing, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61K 47/68 (2017.01); A61K 49/00 (2006.01); A61K 49/16 (2006.01); A61K 49/22 (2006.01); A61K 51/10 (2006.01); A61P 19/08 (2006.01); A61P 43/00 (2006.01); A61P 27/02 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 17/06 (2006.01); A61P 37/08 (2006.01); A61P 19/02 (2006.01); A61P 1/12 (2006.01); A61P 17/14 (2006.01); A61P 17/00 (2006.01); A61P 25/00 (2006.01); A61P 31/04 (2006.01); A61P 1/04 (2006.01); A61P 37/06 (2006.01); A61P 7/06 (2006.01); A61P 29/00 (2006.01); A61P 13/12 (2006.01); A61P 9/02 (2006.01); A61P 37/02 (2006.01); A61P 1/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 39/395 (2013.01); A61K 47/68 (2017.08); A61K 47/6845 (2017.08); A61K 49/0058 (2013.01); A61K 49/16 (2013.01); A61K 49/221 (2013.01); A61K 51/1021 (2013.01); A61P 1/00 (2018.01); A61P 1/04 (2018.01); A61P 1/12 (2018.01); A61P 7/06 (2018.01); A61P 9/02 (2018.01); A61P 11/00 (2018.01); A61P 11/06 (2018.01); A61P 13/12 (2018.01); A61P 17/00 (2018.01); A61P 17/06 (2018.01); A61P 17/14 (2018.01); A61P 19/02 (2018.01); A61P 19/08 (2018.01); A61P 25/00 (2018.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A61P 31/04 (2018.01); A61P 37/02 (2018.01); A61P 37/06 (2018.01); A61P 37/08 (2018.01); A61P 43/00 (2018.01); C07K 16/24 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/52 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); Y02A 50/30 (2018.01);
Abstract
An antibody specifically binding to IL-17A or a functional fragment thereof. The antibody or functional fragment thereof includes an IL-17A chimeric antibody and a functional fragment thereof, and an IL-17A humanized antibody and a functional fragment thereof.